Free Trial

Movano Q4 2022 Earnings Report

Movano logo
$5.75 -0.27 (-4.49%)
(As of 05:00 PM ET)

Movano Earnings Headlines

NIOX COO Adjusts Shareholdings in Strategic Move
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
See More Movano Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Movano? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Movano and other key companies, straight to your email.

About Movano

Movano (NASDAQ:MOVE) engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.

View Movano Profile

More Earnings Resources from MarketBeat

Upcoming Earnings